NF1 and meningioma: In SCBT group, the brain tumor types included non-Neurofibromatosis-1 (NF1) (N = 31, 41.90%) and NF1-related low-grade glioma (N = 11, 14.90%), medulloblastoma (N = 16, 21.60%), germ cell tumors (N = 6, 8.10%), subependymal giant cell astrocytoma (N = 3, 4.10%), ependymoma (N = 2, 2.70%), craniopharyngioma (N = 2, 2.70%), meningioma (N = 1, 1.40%), and other (N = 2, 2.70%).